Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Soda and Milk Study

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
Sábháiltear an nasc chuig an gearrthaisce
StádasCríochnaithe
Urraitheoirí
UCSF Benioff Children's Hospital Oakland
Comhoibritheoirí
Almond Board of California

Keywords

Coimriú

Much attention has been directed at the unhealthy effects of sugar-sweetened beverages (SSBs), as an increase in their consumption has paralleled the rise obesity rates. In adults, SSBs have been shown to promote ectopic fat storage and raise plasma triglycerides compared to equivalent amounts of semi-skim (1.5%) milk, water, or diet beverages. Replacement of soda with milk had the added benefit of also reducing systolic blood pressure. While several studies have investigated the effects of SSBs on weight gain in children, no published studies have investigated their effects on lipid and lipoprotein risk factors under isocaloric conditions in metabolically at-risk adolescents, who are among the greatest consumers of SSBs. The main objective of this study is to test whether isocaloric replacement of soda with reduced fat milk will significantly improve atherogenic dyslipidemia, blood pressure, insulin sensitivity, and liver function in overweight and obese adolescents who are habitual soda consumers. The investigators will test this in a 8 week randomized two period crossover trial in 30 overweight and obese adolescent males who are self-reported habitual consumers of SSBs. Participants will consume energy equivalent amounts of SSB (24oz soda containing high fructose corn syrup per day), and reduced fat milk (2% milk fat) for 3 weeks each, in random order, separated by a 2-week washout. Anthropometrics, blood pressure, and blood samples will be collected at screen and at the end of each intervention period. Plasma measurements will include LDL peak particle diameter; lipoprotein subclass concentrations; triglycerides; total, LDL, and HDL-cholesterol; apolipoproteins; glucose, insulin, and insulin resistance; high sensitivity C-reactive protein; uric acid; and liver enzymes.

Dátaí

Fíoraithe Deireanach: 09/30/2017
Cuireadh isteach den chéad uair: 03/19/2014
Clárú Measta Curtha isteach: 03/20/2014
Arna chur suas ar dtús: 03/23/2014
Nuashonrú Deireanach Curtha isteach: 10/30/2017
Nuashonrú Deireanach Postáilte: 11/05/2017
Dáta Tosaigh an Staidéir Iarbhír: 03/31/2014
Dáta Críochnaithe Bunscoile Measta: 08/31/2016
Dáta Críochnaithe an Staid Mheasta: 04/30/2017

Coinníoll nó galar

Obesity
Dyslipidemia

Idirghabháil / cóireáil

Dietary Supplement: Reduced Fat Milk

Dietary Supplement: Sugar Sweetened Soda

Céim

-

Grúpaí Láimhe

LámhIdirghabháil / cóireáil
Experimental: Reduced Fat Milk
20 oz. reduced fat (2%) milk per day
Dietary Supplement: Reduced Fat Milk
Subjects will be provided with and instructed to consume the equivalent of 20oz. reduced fat milk per day for 3 weeks
Experimental: Sugar Sweetened Soda
24oz. soda per day
Dietary Supplement: Sugar Sweetened Soda
Subjects will be provided with and instructed to consume 2 cans (24oz) of sugar sweetened soda per day for 3 weeks

Critéir Incháilitheachta

Aois Incháilithe le haghaidh Staidéir 13 Years Chun 13 Years
Gnéas Incháilithe le haghaidh StaidéirMale
Glacann Oibrithe Deonacha SláintiúlaSea
Critéir

Inclusion Criteria:

- Males, age 13-18

- Tanner stage ≥ 2

- Self reported sugar sweetened beverage intake 24oz to 60oz per day

- Self reported milk intake ≤16 oz. per day

- BMI 85-99 percentile for age

- Tolerant to milk

Exclusion Criteria:

- History or diagnosis of hypertension or taking blood pressure lowering medication

- History or diagnosis of diabetes, HbA1c ≥ 6.5% or fasting glucose ≥ 126 mg/dl

- Fasting triglyceride > 300 mg/dl

- On lipid lowering or diabetes medication

Toradh

Bearta Toraidh Príomhúla

1. LDL peak particle diameter [3 weeks]

Bearta Torthaí Tánaisteacha

1. Plasma triglycerides [3 weeks]

2. LDL-cholesterol [3 weeks]

3. HDL-cholesterol [3 weeks]

4. Blood pressure [3 weeks]

Systolic and diastolic

5. LDL subclass concentrations [3 weeks]

6. Apolipoprotein B [3 weeks]

7. Apolipoprotein AI [3 weeks]

8. Apolipoprotein CIII [3 weeks]

Bí ar ár
leathanach facebook

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht

  • Oibreacha i 55 teanga
  • Leigheasanna luibhe le tacaíocht ón eolaíocht
  • Aitheantas luibheanna de réir íomhá
  • Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
  • Léigh foilseacháin eolaíochta a bhaineann le do chuardach
  • Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
  • Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní

Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe

Google Play badgeApp Store badge